Myeloid Panel (next generation sequencing)
|Category||Specialist Integrated Haematological Malignancy Diagnostic Service (SIHMDS) >> Molecular Pathology|
An NGS panel used for the investigation of myeloid malignancies such as AML and MDS. This assay covers the following:
Hotspot genes - ABL1, BRAF, CBL, CSF3R, DNMT3A, FLT3, GATA2, HRAS, IDH1, IDH2, JAK2, KIT, KRAS, MPL, MYD88, NPM1, NRAS, PTPN11, SETBP1, SF3B1, SRSF2, U2AF1, WT1
Full genes - ASXL1, BCOR, CALR, CEBPA, ETV6, EZH2, IKZF1, NF1, PHF6, PRPF8, RB1, RUNX1, SH2B3, STAG2, TET2, TP53, ZRSR2
For diagnostic, prognostic and predictive testing in myeloid malignancies such as AML and MDS.
|Sample & container required||4ml Blood or >1ml bone marrow in EDTA (lavender/purple top)|
|Turnaround time||21 calendar days|